Perrigo Hit With Investor Class Action Alleging Misstatements on Infant Formula Business

Overview

• The lawsuit covers Perrigo shares purchased between February 27, 2023 and November 4, 2025.
• Filings allege the Nestlé-acquired infant formula unit suffered underinvestment and manufacturing deficiencies that required spending beyond publicly stated estimates.
• Plaintiffs claim Perrigo overstated earnings and cash flow by understating remediation needs and making misleading statements about the business.
• A Pomerantz notice cites company disclosures on February 27 and May 7, 2024 and August 6, 2025 tied to stock drops, and a November 5, 2025 strategic review with a reassessment of a $240 million investment.
• The notices are attorney advertising that set out allegations rather than court findings and they do not include a response from Perrigo or regulators.